Comparative analysis of echocardiographic and electrocardiographic data of survivors and deceased patients with COVID-19 (sub-analysis of the international register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors”)
https://doi.org/10.15829/1560-4071-2022-4855
Abstract
Aim. To carry out comparative analysis of echocardiographic and electrocardiographic (ECG) data of survivors and deceased patients with COVID-19 (sub-analysis of the international register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors”).
Material and methods. The study presents the results of a sub-analysis of the international AKTIV registry, which was called AKTIV CARDIO. Data were collected from 9 medical centers in the Russian Federation. AKTIV CARDIO included 973 hospitalized patients, of which 50 patients died during hospitalization.
Results. Comparative analysis of echocardiographic parameters revealed that 4 parameters differed in deceased patients compared to survivors: left ventricular ejection fraction (LVEF), right ventricular end diastolic dimension (RV EDD), right atrial (RA) short axis diameter and pulmonary artery systolic pressure (PASP). RA short axis diameter was higher in deceased patients compared with survivors (38,0 [36,0; 39,0] versus 35,0 [33,0; 38,0] mm, p=0,011). RV EDD was higher in deceased patients than in survivors (3,0 [29,0; 33,0] vs 28,0 [27,0; 32,0] mm, p=0,019). LVEF was lower in deceased patients compared with survivors (55 [52; 55] vs 60 [56; 65]%, p<0,001). PASP was higher in deceased patients compared with survivors (25 [21; 35] vs 20 [19; 25] mm Hg, p=0,006). Correlation analysis found that the largest number of correlations with markers of the infection severity was observed for RA short axis diameter and RV EDD. A comparative analysis of ECG data revealed that in deceased patients, compared with survivors, atrial fibrillation (AF) (21,4% vs 6,06%, p=0,001) and supraventricular premature beats (14,3% vs 3,36%, р=0,004) occurred more often. In addition, deceased patients had longer QTc interval (440 [416; 450] vs 400 [380; 430] ms, p<0,001).
Conclusion. Comparative analysis of echocardiographic data showed that deceased patients have more pronounced right heart remodeling, higher PASP and lower LVEF. Patient survival was related to RV and RA sizes. Right heart enlargement was associated with markers of infection severity. Echocardiographic parameters characterizing the right heart side can probably be independent prognostic factors in the acute COVID-19 period.
About the Authors
G. P. ArutyunovRussian Federation
MD, PhD, professor, corresponding member of the Russian Academy of Sciences, President
Moscow
E. I. Tarlovskaya
Russian Federation
MD, PhD, Professor, head of the Department of therapy and cardiology, chairperson of the branch in Nizhny Novgorod
Moscow, Nizhny Novgorod
A. G. Arutyunov
Russian Federation
MD, PhD, secretary general, professor at the department of propedeutics of internal diseases, pediatric School
Moscow
Y. N. Belenkov
Russian Federation
Academician of the Russian Academy of Sciences, MD, PhD, head of Department of hospital therapy №1 medical faculty
Moscow
A. O. Konradi
Russian Federation
Corresponding member of the Russian Academy of Sciences, MD, PhD, Professor, Deputy General Director of scientific work
St. Petersburg
Y. M. Lopatin
Russian Federation
MD, PhD, professor, head of the departrment of cardiology and functional diagnostics, faculty of advanced training for physicians
Volgograd
A. P. Rebrov
Russian Federation
PhD, MD, professor at the department of internal medicine
Saratov
S. N. Tereshchenko
Russian Federation
MD, PhD, professor, head at the department of myocardial diseases and heart failure
Moscow
A. I. Chesnikova
Russian Federation
MD, PhD, professor, professor at the department of internal medicine No.1
Rostov-on-Don
A. R. Vaisberg
Russian Federation
PhD, associate professor at the department of therapy and cardiology
Nizhny Novgoro
N. Y. Grigorieva
Russian Federation
MD, PhD, associate professor, head of the department of clinical medicine
Nizhny Novgorod
B. B. Ogurlieva
Russian Federation
PhD student, сardiologist
Moscow
I. V. Fomin
Russian Federation
MD, PhD, associate professor, head of the department of hospital therapy
Nizhny Novgorod
I. A. Frolova
Russian Federation
Cardiologist
Nizhny Novgorod
O. Yu. Badina
Russian Federation
Head of the infectious diseases department
Nizhny Novgorod
O. E. Vilkova
Russian Federation
PhD, senior lecturer at the department of clinical medicine
Nizhny Novgorod
N. V. Zarechnova
Russian Federation
Deputy chief physician
Nizhny Novgorod
N. A. Kamardina
Russian Federation
Cardiologist
Nizhny Novgorod
E. V. Koroleva
Russian Federation
Physician of the department of cardiology #2 , assistant at the department of of clinical medicine
Nizhny Novgorod
K. V. Mazalov
Russian Federation
Head of the department of cardiology
Nizhny Novgorod
D. V. Soloveva
Russian Federation
Assistant at the department of of clinical medicine
Nizhny Novgorod
References
1. Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AСTIV) and the register “Analysis of hospitalizations of comorbid patients infected during the second wave of SARSCoV-2 outbreak” (AСTIV 2). Russian Journal of Cardiology. 2021;26(3):4358. (In Russ.) doi:10.15829/1560-4071-2021-4358.
2. Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. international register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19. Russian Journal of Cardiology. 2021;26(4):4470. (In Russ.) doi:10.15829/1560-4071-2021-4470.
3. Barman HA, Atici A, Tekin EA, et al. Echocardiographic features of patients with COVID19 infection: a cross-sectional study. Int J Cardiovasc Imaging. 2021;37(3):825-34. doi:10.1007/s10554-020-02051-9.
4. Szekely Y, Lichter Y, Taieb P, et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation. 2020;142(4):342-53. doi:10.1161/CIRCULATIONAHA.120.047971.
5. Golukhova EZ, Slivneva IV, Rybka MM, et al. Right ventricular systolic dysfunction as a predictor of adverse outcome in patients with COVID-19. Kardiologiia. 2020;60(11):16- 29. (In Russ.) doi:10.18087/cardio.2020.11.n1303.
6. Kim J, Volodarskiy A, Sultana R, et al. Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19. J Am Coll Cardiol. 2020;76(17):1965-77. doi:10.1016/j.jacc.2020.08.066.
7. Golukhova EZ, Slivneva IV, Rybka MM, et al. Pulmonary hypertension as a risk assessment factor for unfavorable outcome in patients with COVID-19. Russian Journal of Cardiology. 2020;25(12):4136. (In Russ.) doi:10.15829/1560-4071-2020-4136.
8. Chistyakova MV, Zaitsev DN, Govorin AV, et al. Post-COVID-19 syndrome: morphofunctional abnormalities of the heart and arrhythmias. Russian Journal of Cardiology. 2021;26(7):4485. (In Russ.) doi:10.15829/1560-4071-2021-4485.
9. Kovtyukh IV, Gendlin GE, Nikitin IG, et al. The value of indicators characterizing the state of the cardiovascular system in assessing the hospital prognosis of COVID-19 patients. Kardiologiia. 2021;61(10):26-35. (In Russ.) doi:10.18087/cardio.2021.10.n1553.
10. Krishnamoorthy P, Croft LB, Ro R, et al. Biventricular strain by speckle tracking echocardiography in COVID-19: findings and possible prognostic implications. Future Cardiol. 2021;17(4):663-7. doi:10.2217/fca-2020-0100.
11. Cenko E, Badimon L, Bugiardini R, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA), Cardiovascular Research. 2021;117(14):2705-29. doi:10.1093/cvr/cvab298.
12. Peng Q-Y, Wang X-T, Zhang L-N. Using echocardiography to guide the treatment of novel coronavirus pneumonia. Crit Care. 2020;24(1):143. doi:10.1186/s13054-020-02856-z.
13. Kirkpatrick JN, Grimm R, Johri AM, et al. Recommendations for echocardiography laboratories participating in cardiac point of care cardiac ultrasound (POCUS) and critical care echocardiography training: report from the american society of echocardiography. J Am Soc Echocardiogr. 2020;33(4):409-22. doi:10.1016/j.echo.2020.01.008.
14. Rosén J, Noreland M, Stattin K, et al.; Uppsala Intensive Care COVID-19 Research Group. ECG pathology and its association with death in critically ill COVID-19 patients, a cohort study. PLoS One. 2021;16(12):e0261315. doi:10.1371/journal.pone.0261315.
Supplementary files
Review
For citations:
Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Belenkov Y.N., Konradi A.O., Lopatin Y.M., Rebrov A.P., Tereshchenko S.N., Chesnikova A.I., Vaisberg A.R., Grigorieva N.Y., Ogurlieva B.B., Fomin I.V., Frolova I.A., Badina O.Yu., Vilkova O.E., Zarechnova N.V., Kamardina N.A., Koroleva E.V., Mazalov K.V., Soloveva D.V. Comparative analysis of echocardiographic and electrocardiographic data of survivors and deceased patients with COVID-19 (sub-analysis of the international register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors”). Russian Journal of Cardiology. 2022;27(3):4855. (In Russ.) https://doi.org/10.15829/1560-4071-2022-4855